Further report on evaluation of sodium antimony gluconate in mass treatment of kalaazar by the rate of disappearance of Leishman-Donovan bodies.
D000965:Antimony / Q000627:therapeutic use*; D000967:Antimony Sodium Gluconate; D004396:Coloring Agents; D006801:Humans; D007896:Leishmaniasis / Q000628:therapy*; D008970:Molecular Weight; D012964:Sodium
D004396:Coloring Agents; D000965:Antimony; D012964:Sodium; D000967:Antimony Sodium Gluconate
ANTIMONY/therapeutic use; LEISHMANIASIS/therapy